Feasibility of intraventricular nicardipine prolonged release implants in patients following aneurysmal subarachnoid haemorrhage

British Journal of Neurosurgery

Volumn 25, Issue 6, 2011, Pages 677-683

  Barth, Martin ^a   Pena, Pablo ^a   Seiz, Marcel ^a   Thomé, Claudius ^a   Muench, Elke ^a   Weidauer, Stephan ^b   Hattingen, Elke ^b   Kasuya, Hidetoshi ^c   Schmiedek, Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

aSAH; Nicardipine prolonged release implants

Indexed keywords

ELECTROLYTE; NICARDIPINE; NIMODIPINE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BRAIN INFARCTION; BRAIN VASOSPASM; BRAIN VENTRICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID SHUNTING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; HEART RATE; HUMAN; HYDROCEPHALUS; INCIDENCE; INTRACRANIAL PRESSURE; MALE; MEAN ARTERIAL PRESSURE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE; SUSTAINED DRUG RELEASE;

ADULT; AGED; ANGIOGRAPHY, DIGITAL SUBTRACTION; BRAIN INFARCTION; CEREBRAL VENTRICLES; DELAYED-ACTION PREPARATIONS; DRAINAGE; DRUG IMPLANTS; FEASIBILITY STUDIES; FEMALE; HUMANS; HYDROCEPHALUS; MALE; MIDDLE AGED; NICARDIPINE; PROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 82355183639     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.3109/02688697.2010.548878     Document Type: Article

References (12)

1. Fergusen S, Macdonald RL. Predictors of cerebral infarction in patients with aneurysmal subarachnoid haemorrhage. Neuro-surgery 2007;60:658-67; discussion 667. (Pubitemid 46581089)
2. Weidauer S, Lanfermann H, Raabe A, Zanella F, Seifert V, Beck J. Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid haemorrhage: a prospective MRI and DSA study. Stroke 2007;38:1831-6. (Pubitemid 46847255)
3. Weyer GW, Nolan CP, Macdonald RL. Evidence-based cerebral vasospasm management. Neurosurg Focus 2006;21:E8.
4. Kasuya H, Onda H, Takeshita M, Okada Y, Hori T. Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke 2002;33:1011-15. (Pubitemid 34293584)
5. Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T. Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid haemorrhage. Neurosurgery 2005;56:895-902; discussion 895-902.
6. Krischek B, Kasuya H, Onda H, Hori T. Nicardipine prolonged-release implants for preventing cerebral vasospasm after subarachnoid haemorrhage: effect and outcome in the first 100 patients. Neurol Med Chir (Tokyo) 2007;47:389-94; discussion 394-6. (Pubitemid 47535629)
7. Barth M, Capelle HH, Weidauer S, et al. Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid haemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke 2007;38:330-6. (Pubitemid 46188258)
8. Cowan JA Jr, Ziewacz J, Dimick JB, Upchurch GR Jr. Thompson BG use of endovascular coil embolization and surgical clip occlusion for cerebral artery aneurysms. J Neurosurg 2007;107:530-5. (Pubitemid 47451035)
9. Tuettenberg J, Czabanka M, Horn P, et al. Clinical evaluation of the safety and efficacy of lumbar cerebrospinal fluid drainage for the treatment of refractory increased intracranial pressure. J Neurosurg 2009;110:1200-8.
10. Raabe A, Beck J, Berkefeld J, et al. Recommendations for the management of patients with aneurysmal subarachnoid haemorrhage. Zentralbl Neurochir 2005;66:79-91. (Pubitemid 40676476)
11. Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid haemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008;39:3015-21.
12. Kreiter KT, Mayer SA, Howard G, et al. Sample size estimates for clinical trials of vasospasm in subarachnoid haemorrhage. Stroke 2009;40:2362-7.